These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study. Schmerber S, Dumas G, Morel N, Chahine K, Karkas A. Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499 [Abstract] [Full Text] [Related]
8. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients. Convert C, Franco-Vidal V, Bebear JP, Darrouzet V. Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517 [Abstract] [Full Text] [Related]
9. [Intratympanic gentamicin treatment for intractable Menière's disease]. Gilony D, Wolf M, Kronenberg J. Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278 [Abstract] [Full Text] [Related]
10. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
11. Hearing results following intratympanic gentamicin perfusion for Ménière's disease. Kyrodimos E, Aidonis I, Sismanis A. J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493 [Abstract] [Full Text] [Related]
12. [Vestibular neurotomy versus chemical labyrinthectomy for disabling Menière disease]. Morel N, Dumas G, Nguyen DQ, Mohr E, Hitter A, Schmerber S. Ann Otolaryngol Chir Cervicofac; 2005 Dec; 122(6):271-80. PubMed ID: 16505777 [Abstract] [Full Text] [Related]
13. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial. Postema RJ, Kingma CM, Wit HP, Albers FW, Van Der Laan BF. Acta Otolaryngol; 2008 Aug; 128(8):876-80. PubMed ID: 18607963 [Abstract] [Full Text] [Related]
14. Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy. Ferber-Viart C, Dubreuil C, Vidal PP. Audiol Neurootol; 2009 Aug; 14(1):17-25. PubMed ID: 18663295 [Abstract] [Full Text] [Related]
15. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops. Yazdi AK, Rutka J. J Otolaryngol; 1996 Feb; 25(1):26-31. PubMed ID: 8816106 [Abstract] [Full Text] [Related]
16. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Hillman TA, Chen DA, Arriaga MA. Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193 [Abstract] [Full Text] [Related]
17. [Meniere's disease: diagnosis and new treatment perspectives]. Quaranta A, Piazza F. Recenti Prog Med; 2000 Jan; 91(1):33-7. PubMed ID: 10705783 [Abstract] [Full Text] [Related]
18. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review. Li CS, Lai JT. Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995 [Abstract] [Full Text] [Related]